Eli Lilly
Trade Eli Lilly 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About LLY
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies.
LLY Key Statistics
Stock Snapshot
Eli Lilly(LLY) stock is priced at $1,219.54, giving the company a market capitalization of 1.26T. It carries a P/E multiple of 40.36 and pays a dividend yield of 0.58%.
On 2026-08-12, Eli Lilly(LLY) stock traded between a low of $1,191.08 and a high of $1,219.99. Shares are currently priced at $1,219.54, which is +2.4% above the low and -0.0% below the high.
The Eli Lilly(LLY)'s current trading volume is 513.04K, compared to an average daily volume of 3.3M.
During the past year, Eli Lilly(LLY) stock moved between $629.40 at its lowest and $1,249.45 at its peak.
During the past year, Eli Lilly(LLY) stock moved between $629.40 at its lowest and $1,249.45 at its peak.
LLY News
These 7 Stocks Are Analyst Favorites For Magnificent Earnings Growth; Arista Beats Views 8/08/2026 Among the best stocks in earnings performance, highly rated...
Pharmaceutical giant Eli Lilly (LLY) has filed lawsuits against six U.S. companies that it accuses of illegally selling black-market versions of its experiment...
Eli Lilly has sued six companies, saying they are illegally selling versions of the unapproved weight-loss drug retatrutide. Eli Lilly is suing six pharmacies...
Analyst ratings
81%
of 31 ratingsMore LLY News
Eli Lilly & Co. (LLY), the manufacturer of weight-loss drugs Mounjaro and Zepbound, has filed six lawsuits against U.S. businesses for illegally selling version...
Eli Lilly & Co. is stepping up its fight against a booming black market for retatrutide, an experimental drug that the company is counting on to expand its cruc...
Amazon Pharmacy launches a program to offer Eli Lilly (NYSE: LLY) weight-loss drug Zepbound to eligible Medicare patients for US$50 per month using a new federa...
Key Points Eli Lilly has a stronger GLP-1 portfolio and pipeline than Novo Nordisk. Eli Lilly also has a better lineup outside the diabetes and weight-loss ar...
Eli Lilly’s (LLY) stock was up about 2% in early trading on Aug. 11 on news that the company’s weight loss pill Foundayo has been approved for sale in the Unite...
Eli Lilly (NYSE: LLY) has entered a new clinical trial collaboration with Amplia Therapeutics to test a novel drug combination in non-small cell lung cancer. T...
Key Points This market has a population of almost 60 million. While the drug isn't the first of its type to be sold in that country, it will have Lilly's cons...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.